Basic Information
| LncRNA/CircRNA Name | LINC00346 |
| Synonyms | NA |
| Region | GRCh38_13:110863987-110870251 |
| Ensemble | ENSG00000255874 |
| Refseq | NR_027701 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | Microarray |
| Sample | GC tissue |
| Expression Pattern | up-regulated |
| Function Description | The LINC00346 gene was recurrently amplified and upregulated in GC, and its expression was positively correlated with poor pathologic stage, large tumor size, and poor prognosis. |
| Pubmed ID | 30770877 |
| Year | 2019 |
| Title | KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome. |
External Links
| Links for LINC00346 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |